When to Trust a Preprint: A Decision Guide for Researchers and Clinicians

By Dr. Zubair Khalid, DVM, MS, PhD ·

When to Trust a Preprint: A Decision Guide for Researchers and Clinicians

Quick Answer

  • Trust a preprint when the study type is descriptive or methodological, the authors have verifiable institutional affiliations, and the data and analysis code are openly available for inspection.
  • Verify whether the same work has undergone peer review elsewhere, such as a journal publication or conference proceedings, before applying findings to clinical or policy decisions.
  • A preprint has not been formally peer reviewed, so treat any treatment recommendation, safety claim, or regulatory implication as provisional until independent verification.

At a Glance

Decision FactorWhat to CheckWhen It Supports Trust
Study typeRandomized trial, observational study, modeling paper, or case reportDescriptive and methodological studies carry lower risk than interventional claims
Author reputationORCID record, institutional page, prior publication historyVerified identity and consistent research record in the same field
Data availabilityRaw data, analysis code, or detailed methods posted openlyFull transparency allows independent replication and error detection
Peer review statusJournal submission history, conference presentation, or published versionA published version in a recognized journal strengthens confidence
Reporting qualityUse of reporting guidelines such as CONSORT or STROBEAdherence to guidelines signals methodological discipline
Funding and conflictsFunding sources and conflict-of-interest statementsClear disclosure of funding and competing interests supports evaluation

Understanding the Preprint Landscape

Preprints are complete scientific manuscripts that researchers post on public servers before formal journal peer review. They allow rapid sharing of findings, early feedback from the community, and open access to research that might otherwise remain behind paywalls. The National Library of Medicine provides access to biomedical books and research-method references that can help readers understand how preprints fit into the broader scientific communication system.

The pressure to use preprints comes from several directions. Researchers want early access to new findings. Clinicians face patients who have read about preprint results in the news. Journalists and policy makers need timely evidence during public health emergencies. These pressures create a practical problem: how do you decide when a preprint is reliable enough to inform your work?

The answer depends on what you plan to do with the information. A preprint that describes a new laboratory method may be safe to use as a starting point for your own experiments. The same preprint would not be safe to use as the basis for changing a clinical protocol. The decision framework in this article separates the question of whether a preprint is credible from the question of whether it is ready for application.

Core Principles for Evaluating Preprints

Peer Review Status

Peer review is the formal process by which independent experts evaluate a manuscript before journal publication. The Committee on Publication Ethics (COPE) Core Practices describe the responsibilities of journals and editors in managing peer review, including the expectation that reviewers assess the work fairly and that journals handle submissions transparently. A preprint has not gone through this process, so it lacks the quality assurance that peer review provides.

The absence of peer review does not mean the work is wrong. It means the work has not been independently checked. Some preprints later appear in peer-reviewed journals with changes. Others never undergo formal review. The status of the preprint matters for how much weight you give it.

Author Identity and Reputation

Author identity is a practical starting point for evaluating a preprint. ORCID provides a persistent digital identifier that distinguishes researchers and connects them to their research activities. A researcher with an ORCID record that shows a consistent history of publications in the relevant field is easier to evaluate than an author with no verifiable record.

Check the author's institutional affiliation and whether that institution is recognized in the field. Look at the author's prior publications to see whether they have a track record of rigorous work. An author who has published in peer-reviewed journals on the same topic is more likely to produce a credible preprint than an unknown author with no prior record.

Data Availability and Transparency

The National Institutes of Health (NIH) Data Management and Sharing Policy describes expectations for planning and managing data generated from NIH-funded research. The policy emphasizes that data should be shared in a way that is consistent with the research and that data management plans should be included in grant applications. This policy reflects a broader movement toward transparency in research.

A preprint that includes the full data, analysis code, and methods is easier to evaluate than one that provides only a summary. You can check whether the analysis is reproducible and whether the conclusions follow from the data. A preprint that does not provide data or methods in sufficient detail is harder to trust because you cannot verify the work.

Reporting Guidelines

The EQUATOR Network provides reporting guidelines for health research, including CONSORT for randomized trials, STROBE for observational studies, and PRISMA for systematic reviews. These guidelines describe the minimum information that should be included in a research report. A preprint that follows a reporting guideline is more likely to include the details needed for evaluation.

When you read a preprint, check whether it includes the elements required by the relevant reporting guideline. For example, a randomized trial should describe how participants were assigned to groups, how blinding was handled, and how the sample size was determined. A preprint that omits these details is harder to evaluate.

Practical Workflow for Evaluating a Preprint

Step 1: Identify the Study Type

The first step is to identify the type of study described in the preprint. Randomized trials, observational studies, modeling studies, and laboratory experiments have different standards of evidence. A randomized trial that claims a treatment effect requires more scrutiny than a descriptive study that reports the prevalence of a condition.

Step 2: Check the Authors

Verify the authors' identities and affiliations. Look for ORCID records, institutional pages, and prior publications. An author with a verifiable record in the same field is more credible than an anonymous author. Check whether the authors have declared any conflicts of interest.

Step 3: Assess Data Availability

Determine whether the data and methods are available for inspection. The NIH Data Management and Sharing Policy describes the expectations for data sharing in NIH-funded research. A preprint that includes data and code is easier to verify than one that does not.

Step 4: Evaluate Reporting Quality

Check whether the preprint follows the relevant reporting guideline from the EQUATOR Network. A preprint that includes the required elements is more likely to be complete and transparent.

Step 5: Determine Peer Review Status

Check whether the preprint has been submitted to a journal or has been published elsewhere. A preprint that has been accepted for publication in a peer-reviewed journal has undergone additional scrutiny. A preprint that has not been submitted anywhere has not been independently.

Step 6: Decide Whether to Use the Findings

The final step is to decide whether the preprint is ready for your intended use. A preprint that passes the first five steps may be suitable for informing your own research. A preprint that does not pass these steps should not be used for clinical or policy decisions.

Options and Tradeoffs in Using Preprints

Using Preprints for Research

Preprints can be useful for researchers who want early access to new findings. A preprint that includes data and methods can be used to replicate the analysis or to design a follow-up study. The trade-off is that the preprint has not been peer-reviewed, so the findings may change after formal review.

Using Preprints for Clinical Decisions

Preprints are not appropriate for clinical decisions unless the findings have been independently verified. A preprint that claims a treatment is effective should not be used to change clinical practice without confirmation from a peer-reviewed publication or a formal guideline. The risk of using an unverified preprint for clinical decisions is that the findings may be wrong.

Using Preprints for Policy Decisions

Policy decisions require a higher standard of evidence than research decisions. A preprint that informs a policy decision should be supported by additional evidence from peer-reviewed sources. The policy decision should be based on the full body of evidence, not on a single preprint.

Observations and Measurements

What to Record When Evaluating a Preprint

When you evaluate a preprint, record the following information:

  • The preprint title and the date it was posted
  • The authors and their institutional affiliations
  • The study type and the reporting guideline that applies
  • The data availability statement and whether the data are accessible
  • The peer review status, including any journal submission or publication
  • The funding sources and any conflicts of interest

This record helps you track your evaluation and compare preprints over time.

How to Measure the Quality of a Preprint

The quality of a preprint can be measured by the completeness of its reporting, the availability of its data, and the verifiability of its authors. A preprint that follows a reporting guideline and provides data is more transparent than one that does not. The quality of a preprint is not measured by the prominence of the authors or the journal where it was posted.

Common Failure Patterns in Preprint Evaluation

Overreliance on Author Reputation

A common failure is to trust a preprint because the authors are well known. Author reputation is a useful signal, but it does not replace the need for data and methods. A well-known author can produce a flawed preprint.

Ignoring the Absence of Peer Review

Another failure is to treat a preprint as if it had been peer-reviewed. A preprint that has not been through peer review has not been independently evaluated. The absence of peer review is a limitation that should be acknowledged.

Confusing Preprint with Publication

A preprint is not a publication. A preprint that has been posted on a server has not been published in a peer-reviewed journal. The distinction matters because the peer review process adds a layer of verification that a preprint does not have.

Failing to Check Data Availability

A preprint that does not provide data is harder to evaluate. The absence of data may be a sign that the authors are not willing to share their work. The NIH Data Management and Sharing Policy emphasizes the importance of data sharing for NIH-funded research, and this expectation is a useful standard for evaluating preprints.

Limitations and Safety Context

Limitations of Preprints

Preprints have several limitations. They have not been peer-reviewed, so they may contain errors. They may be revised or withdrawn after posting. They may not include the data or methods needed for verification. These limitations mean that preprints should be used with caution.

Safety Context for Clinical and Policy Decisions

The safety context for preprints is important. A preprint that makes a clinical claim should not be used to change practice without independent verification. A preprint that makes a policy claim should not be used to change policy without a full review of the evidence. The safety of patients and the public depends on the use of verified evidence.

Professional Escalation Criteria

If you are a clinician or a researcher and you are considering using a preprint for a decision, escalate the decision to a supervisor or a colleague with relevant expertise. If the preprint makes a claim that could affect patient safety, do not use the preprint until the claim has been verified. If the preprint is from a source that you cannot verify, do not use it.

Building a Preprint Verification File: A Structured Record System

A recurring weakness in preprint evaluation is that readers assess a manuscript once, form an impression, and then lose the details that informed their judgment. When the same preprint resurfaces in a journal club, a grant review, or a clinical discussion weeks later, the original reasoning is gone. A structured record system solves this problem by turning an informal assessment into a documented, comparable, and auditable process. This section provides a practical framework for building a preprint verification file that you can maintain for every manuscript you seriously evaluate.

The Purpose of a Verification File

A verification file is a dated, structured record of the checks you performed on a preprint and the evidence you found. It serves three functions. First, it forces you to complete each evaluation step instead of stopping after a quick read of the abstract. Second, it creates a comparison baseline so you can judge whether a revised preprint or a published version has meaningfully changed. Third, it gives you a defensible basis for explaining to a colleague, supervisor, or patient why you did or did not rely on a particular finding.

The file does not need to be elaborate. A spreadsheet, a notes document, or a paper form works equally well. What matters is that the same fields are completed for every preprint you evaluate so that comparisons across manuscripts are meaningful.

The Nine Field Preprint Scorecard

The scorecard below uses nine fields that map directly to the evaluation principles described earlier in this article. Each field requires a concrete observation, not a general impression. The fields are designed to be completed in about fifteen minutes per preprint, which is a reasonable investment for any manuscript that might influence your work.

Field 1: Preprint identifier and version. Record the server, the DOI or accession number, the title, and the date the version was posted. Preprints are often revised, so note the version number if the server provides one. This field is the anchor for all other records.

Field 2: Study type and reporting guideline. Identify the study design and the corresponding reporting guideline from the EQUATOR Network. For a randomized trial, the guideline is CONSORT. For an observational study, it is STROBE. For a systematic review, it is PRISMA. If the study type does not have a recognized guideline, record that as an observation. This field tells you what reporting elements you should expect to find.

Field 3: Author verification. List the authors and check whether each has an ORCID record, a verifiable institutional affiliation, and a publication history in the relevant field. Record the number of authors you could verify and the number you could not. An author with an ORCID record that links to prior work in the same area is a stronger signal than an author with no verifiable identity.

Field 4: Data availability statement. Record what the preprint says about data availability. Does it state that data are available? Does it provide a repository link or an accession number? Does it say data are available on request? Does it omit a data availability statement entirely? The NIH Data Management and Sharing Policy describes the expectations for data sharing in NIH-funded research, and this policy is a useful benchmark for what a complete data statement should contain.

Field 5: Analysis code and materials. Record whether the preprint provides analysis code, scripts, or detailed methods that would allow replication. A preprint that includes code is easier to verify than one that describes methods in prose only. If the code is in a public repository, record the repository name and the identifier.

Field 6: Reporting completeness. Using the relevant reporting guideline, check whether the preprint includes the required elements. For a randomized trial, this includes the method of randomization, the blinding procedure, the sample size calculation, and the flow of participants. For an observational study, it includes the eligibility criteria, the exposure and outcome definitions, and the statistical methods. Record the number of required elements present and the number missing.

Field 7: Peer review status. Record whether the preprint has been submitted to a journal, accepted for publication, or published in a peer-reviewed venue. Check the preprint server for a link to a published version. Search for the title or the authors in a journal database. If you find a published version, record the journal name and the publication date.

Field 8: Funding and conflicts. Record the funding sources and any conflict of interest statements. The Committee on Publication Ethics Core Practices describe the expectations for transparency in funding and competing interests. A preprint that discloses funding and conflicts is easier to evaluate than one that omits these statements.

Field 9: Your intended use and decision. Record the purpose for which you are evaluating the preprint. Is it to inform your own research design? To update a literature review? To consider a clinical protocol change? To inform a policy position? Then record your decision: use, use with caution, or do not use. This field forces you to connect the evaluation to the application.

Scoring and Interpreting the Scorecard

Each field can be scored on a simple three point scale: adequate, partial, or inadequate. An adequate score means the preprint fully satisfies the check. A partial score means the preprint provides some information but not enough for full verification. An inadequate score means the preprint does not provide the information at all.

A preprint that scores adequate on data availability, analysis code, and reporting completeness is a candidate for use in research planning. A preprint that scores inadequate on any of these fields should not be used for clinical or policy decisions. The scorecard does not replace judgment, but it does make the basis for judgment explicit.

A Practical Worked Example

Consider a preprint that reports a secondary analysis of a randomized trial. The preprint includes a data availability statement with a repository link, provides the analysis code in a public repository, and follows the CONSORT extension for cluster randomized trials. The authors have ORCID records and institutional affiliations. The preprint has been submitted to a journal but has not yet been published.

The scorecard would show adequate scores for data availability, analysis code, reporting completeness, and author verification. The peer review status field would show a partial score because the manuscript is under review but not yet published. The overall assessment would be that the preprint is suitable for informing a research design or a systematic review, but not for changing clinical practice until the peer-reviewed version appears.

Contrast this with a preprint that reports a new treatment effect but provides no data availability statement, no analysis code, and no reporting guideline adherence. The authors have no verifiable ORCID records. The scorecard would show inadequate scores on the key verification fields. The overall assessment would be that the preprint is not suitable for any application beyond a preliminary scan of the literature.

Common Failure Patterns in Record Keeping

The most common failure in preprint evaluation is not keeping a record at all. A second failure is keeping a record that captures only the final decision without the evidence. A third failure is treating the scorecard as a pass fail test instead of a structured judgment tool. A preprint can score adequately on most fields and still contain a fatal flaw that the scorecard does not capture. The scorecard is a starting point, not a substitute for reading the manuscript.

Another failure is updating the scorecard when the preprint changes. Preprints are often revised after community feedback or after journal review. A version that was inadequate in its first posting may be adequate in its second. A version that was adequate may be withdrawn. The scorecard should be updated whenever you become aware of a new version or a change in peer review status.

Practical Implementation Steps

To build a working preprint verification system, follow these steps.

Step 1: Create a template. Build a spreadsheet or document with the nine fields described above. Add a column for the date of your evaluation and a column for the date of any update.

Step 2: Set a threshold for evaluation. Decide in advance which preprints you will evaluate in full. A reasonable threshold is any preprint that you are considering using for a research design, a clinical protocol, or a policy position. Preprints that you read for general awareness do not need a full scorecard.

Step 3: Complete the scorecard within one working day. The evaluation is most accurate when the preprint is fresh in your mind. Do not rely on memory. Record the evidence as you find it.

Step 4: Review the scorecard before any decision. Before you use a preprint for a substantive purpose, review the scorecard and confirm that your decision matches the evidence. If the scorecard shows inadequate data availability but you are still considering using the findings, that is a signal to stop and escalate.

Step 5: Update the scorecard when the status changes. Check periodically whether the preprint has been published, revised, or withdrawn. Update the peer review status field and the overall assessment accordingly.

Professional Escalation Criteria

The scorecard also provides a structured basis for escalation. If you are a clinician or a researcher and the scorecard shows inadequate data availability, inadequate reporting completeness, or an unverifiable author, escalate the decision to a supervisor or a colleague with relevant expertise before using the preprint. If the preprint makes a claim that could affect patient safety, do not use the preprint until the claim has been verified through a peer-reviewed publication or a formal guideline. If the preprint is from a source that you cannot verify, do not use it.

The scorecard does not replace professional judgment. It supports it by making the evidence visible and the reasoning explicit. A structured record system is the difference between a vague impression that a preprint seems credible and a documented basis for a decision that you can defend to a colleague, a supervisor, or a patient.

Frequently Asked Questions

What is the difference between a preprint and a peer-reviewed article?

A preprint is a manuscript that has been posted to a public server before formal peer review. A peer-reviewed article has been evaluated by independent experts and published in a journal. The peer review process provides a layer of scrutiny that a preprint does not have.

How can I check whether a preprint has been peer-reviewed?

You can check the preprint server for a link to a published version. You can also search for the title or the authors in a journal database. If the preprint has been published in a peer-reviewed journal, the journal version is the one to use.

What should I do if a preprint makes a clinical claim?

Do not use the preprint to change clinical practice. The claim should be verified through a peer-reviewed publication or a formal guideline. If you are a clinician, you should consult with a colleague or a supervisor before making a decision based on a preprint.

How can I verify the authors of a preprint?

You can check the authors' ORCID records, institutional affiliations, and prior publications. ORCID provides a persistent identifier that distinguishes researchers from each other. A researcher with a verifiable record is easier to trust than an anonymous author.

What should I do if a preprint does not provide data?

If a preprint does not provide data, you should be cautious about using the findings. The data are needed to verify the analysis. The NIH Data Management and Sharing Policy describes the expectations for data sharing in NIH-funded research, and this expectation is a useful standard for evaluating preprints.

How can I use reporting guidelines to evaluate a preprint?

The EQUATOR Network provides reporting guidelines for different study types. You can check whether the preprint follows the relevant guideline. A preprint that follows a reporting guideline is more likely to include the details needed for evaluation.

What is the role of the Committee on Publication Ethics in preprint evaluation?

The Committee on Publication Ethics (COPE) Core Practices describe the responsibilities of journals in managing peer review, authorship, data, conflicts of interest, and misconduct. These practices provide a reference for understanding the standards that apply to published research. A preprint that does not meet these standards may be less reliable.

When should I escalate a preprint decision to a supervisor?

You should escalate a preprint decision to a supervisor or a peer when the preprint could affect patient safety, when the preprint is from an unverified source, or when you are unsure about the quality of the preprint. The escalation criteria are designed to protect the quality of decisions.

Using the Evidence

SourceBest use in this topicImportant limitation
Research Methods Resourcesofficial guidanceCheck the linked page for current local requirements
EQUATOR Networkofficial guidanceCheck the linked page for current local requirements
Core Practicesofficial guidanceCheck the linked page for current local requirements

Related Articles

References and Further Reading

This article is educational and does not replace institutional policy, professional advice, or applicable safety and regulatory requirements.